Back
Citius Oncology, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
53
CTOR
Citius Oncology, Inc.
Last Price:
$1.38
Seasonality Move:
-13.44%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and CTOR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Citius Oncology, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.15 | Buy |
| 20-day SMA: | 1.2 | Buy |
| 50-day SMA: | 1.42 | Sell |
| 200-day SMA: | 1.54 | Sell |
| 8-day EMA: | 1.19 | Buy |
| 20-day EMA: | 1.22 | Buy |
| 50-day EMA: | 1.38 | Buy |
| 200-day EMA: | 1.92 | Sell |
Citius Oncology, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 57.01 | Buy |
| Chaikin Money Flow: | 1708034 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.08 - 1.32) | Buy |
| Bollinger Bands (100): | (1.33 - 1.95) | Sell |
Citius Oncology, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Citius Oncology, Inc. Stock
Is Citius Oncology, Inc. Stock a Buy?
-
Citius Oncology, Inc. share price is 1.39 while CTOR 8-day simple moving average is 1.15, which is a Buy signal.
-
The stock price of CTOR is 1.39 while Citius Oncology, Inc. 20-day SMA is 1.20, which makes it a Buy.
-
Citius Oncology, Inc. 50-day simple moving average is 1.42 while CTOR share price is 1.39, making it a Sell technically.
-
CTOR stock price is 1.39 and Citius Oncology, Inc. 200-day simple moving average is 1.54, creating a Sell signal.
CTOR Technical Analysis vs Fundamental Analysis
Buy
53
Citius Oncology, Inc. (CTOR)
is a Buy
Is Citius Oncology, Inc. a Buy or a Sell?
-
Citius Oncology, Inc. stock is rated a BuyThe current Citius Oncology, Inc. [CTOR] share price is $1.39. The Score for CTOR is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
Citius Oncology, Inc. Stock Info
Market Cap:
108.9M
Price in USD:
1.39
Share Volume:
2.7M
Citius Oncology, Inc. 52-Week Range
52-Week High:
6.19
52-Week Low:
0.55
Buy
53
Citius Oncology, Inc. (CTOR)
is a Buy
Citius Oncology, Inc. Share Price Forecast
-
What is the Citius Oncology, Inc. stock price today?The Citius Oncology, Inc. stock price is 1.39 USD today.
-
Will CTOR stock go up or go down?Citius Oncology, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Citius Oncology, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Citius Oncology, Inc. is not overvalued.
Is Citius Oncology, Inc. Stock a Buy?
-
Citius Oncology, Inc. share price is 1.39 while CTOR 8-day exponential moving average is 1.19, which is a Buy signal.
-
The stock price of CTOR is 1.39 while Citius Oncology, Inc. 20-day EMA is 1.22, which makes it a Buy.
-
Citius Oncology, Inc. 50-day exponential moving average is 1.38 while CTOR share price is 1.39, making it a Buy technically.
-
CTOR stock price is 1.39 and Citius Oncology, Inc. 200-day simple moving average is 1.92, creating a Sell signal.
Technical Analysis of Citius Oncology, Inc.
Should I short Citius Oncology, Inc. stock?
-
CTOR Moving Average Covergence Divergence (MACD) indicator is -0.06, suggesting Citius Oncology, Inc. is a Sell
-
Citius Oncology, Inc. Relative Strength Index (RSI) is 57.01, which suggest Citius Oncology, Inc. is overbought
-
The Bollinger Bands (25) for Citius Oncology, Inc. is (1.08 - 1.32), which suggest Citius Oncology, Inc. is a Sell
-
The Bollinger Bands (100) for Citius Oncology, Inc. is (1.33 - 1.95), which suggest Citius Oncology, Inc. is a Sell
* Citius Oncology, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.